Author

Sachiko Nakamori

National Heart, Lung, and Blood Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Danielle SpringeriD· 2 shared Abucar Mohamed· 1 shared Alan Thomas RemaleyiD· 1 shared Alison M. MaleiD· 1 shared Aloysius DomingoiD· 1 shared Alyssa GroganiD· 1 shared Amjad Ullah KhaniD· 1 shared Amy E. Crunk· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Danielle SpringerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCellPeer-reviewedOct 1, 2026

Immunoregulatory gene GIMAP6 suppresses lethal atherosclerotic vasculopathy and ischemic heart failure

Xiang Chen, Kaja S. Arusha, Danielle Springer…·Michael J. Lenardo

This study shows that GIMAP6 loss leads to inflammatory vasculopathy and atherosclerosis, causing heart failure and early death, and identifies GIMAP6 as a protective factor against cardiovascular disease.

DOI 10.1016/j.cell.2026.09.032

humanexperimental assay

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintFeb 28, 2026

Clinical, in vitro, and in vivo evidence of WAPL as a novel cohesinopathy gene and phenotypic driver of 10q22.3q23.2 genomic disorder

Philip M. Boone, Serkan Erdin, Abucar Mohamed…·Ilaria Parenti

The paper identifies WAPL as a novel cohesinopathy gene and driver of a genomic disorder, showing its role in developmental delay and other anomalies through clinical, in vitro, and in vivo analyses.

DOI 10.64898/2026.02.23.26346364

humanexperimental assay

𝕏 PostBluesky